Am J Psychiatry 160:105-111, January 2003
© 2003 American Psychiatric Association
Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial
Harrison G. Pope, Jr., M.D.,
Geoffrey H. Cohane, B.A.,
Gen Kanayama, M.D., Ph.D.,
Arthur J. Siegel, M.D., and
James I. Hudson, M.D., Sc.D.
OBJECTIVE: Testosterone supplementation may produce antidepressant effects in men, but until recently it has required cumbersome parenteral administration. In an 8-week randomized, placebo-controlled trial, the authors administered a testosterone transdermal gel to men aged 30–65 who had refractory depression and low or borderline testosterone levels. METHOD: Of 56 men screened, 24 (42.9%) displayed morning serum total testosterone levels of 350 ng/dl or less (normal range=270–1070). Of these men, 23 entered the study. One responded to an initial 1-week single-blind placebo period, and 22 were subsequently randomly assigned: 12 to 1% testosterone gel, 10 g/day, and 10 to identical-appearing placebo. Each subject continued his existing antidepressant regimen. Ten subjects receiving testosterone and nine receiving placebo completed the 8-week trial. RESULTS: The groups were closely matched on baseline demographic and psychiatric measures. Subjects receiving testosterone gel had significantly greater improvement in scores on the Hamilton Depression Rating Scale than subjects receiving placebo. These changes were noted on both the vegetative and affective subscales of the Hamilton Depression Rating Scale. A significant difference was also found on the Clinical Global Impression severity scale but not the Beck Depression Inventory. One subject assigned to testosterone reported increased difficulty with urination, suggesting an exacerbation of benign prostatic hyperplasia; no other subject reported adverse events apparently attributable to testosterone. CONCLUSIONS: These preliminary findings suggest that testosterone gel may produce antidepressant effects in the large and probably underrecognized population of depressed men with low testosterone levels.
This article has been cited by other articles:
|
|
|
|
 
P. E. Knapp, T. W. Storer, K. L. Herbst, A. B. Singh, C. Dzekov, J. Dzekov, M. LaValley, A. Zhang, J. Ulloor, and S. Bhasin
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss
Am J Physiol Endocrinol Metab,
June 1, 2008;
294(6):
E1135 - E1143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. P. Almeida, B. B. Yeap, G. J. Hankey, K. Jamrozik, and L. Flicker
Low Free Testosterone Concentration as a Potentially Treatable Cause of Depressive Symptoms in Older Men
Arch Gen Psychiatry,
March 1, 2008;
65(3):
283 - 289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bloch, D. R. Rubinow, K. Berlin, K. R. Kevala, H.-Y. Kim, and P. J. Schmidt
Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
Arch Gen Psychiatry,
April 1, 2006;
63(4):
450 - 456.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. K. Gershenfeld, R. A. Philibert, and G. W. Boehm
Looking Forward in Geriatric Anxiety and Depression: Implications of Basic Science for the Future
Am J Geriatr Psychiatry,
December 1, 2005;
13(12):
1027 - 1040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Kaufman and A. Vermeulen
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Endocr. Rev.,
October 1, 2005;
26(6):
833 - 876.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. Gray, A. B. Singh, L. J. Woodhouse, T. W. Storer, R. Casaburi, J. Dzekov, C. Dzekov, I. Sinha-Hikim, and S. Bhasin
Dose-Dependent Effects of Testosterone on Sexual Function, Mood, and Visuospatial Cognition in Older Men
J. Clin. Endocrinol. Metab.,
July 1, 2005;
90(7):
3838 - 3846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Orengo, L. Fullerton, and M. E. Kunik
Safety and Efficacy of Testosterone Gel 1% Augmentation in Depressed Men With Partial Response to Antidepressant Therapy
J Geriatr Psychiatry Neurol,
March 1, 2005;
18(1):
20 - 24.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. K. Miller, K. A. Grieco, and A. Klibanski
Testosterone Administration in Women with Anorexia Nervosa
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1428 - 1433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Schmidt, K. L. Berlin, M. A. Danaceau, A. Neeren, N. A. Haq, C. A. Roca, and D. R. Rubinow
The Effects of Pharmacologically Induced Hypogonadism on Mood in Healthy Men
Arch Gen Psychiatry,
October 1, 2004;
61(10):
997 - 1004.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Charney
Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress
Focus,
July 1, 2004;
2(3):
368 - 391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Shames, E. M. Schaeffer, P. C. Walsh, G. Redmond, R. M. Harris, A. Morgentaler, and E. L. Rhoden
Risks of Testosterone Replacement
N. Engl. J. Med.,
May 6, 2004;
350(19):
2004 - 2006.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Evans
Current Concepts in Anabolic-Androgenic Steroids
Am. J. Sports Med.,
March 1, 2004;
32(2):
534 - 542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Charney
Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress
Am J Psychiatry,
February 1, 2004;
161(2):
195 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Shores, K. L. Sloan, A. M. Matsumoto, V. M. Moceri, B. Felker, and D. R. Kivlahan
Increased Incidence of Diagnosed Depressive Illness in Hypogonadal Older Men
Arch Gen Psychiatry,
February 1, 2004;
61(2):
162 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Kenny, G. Fabregas, C. Song, B. Biskup, and S. Bellantonio
Effects of Testosterone on Behavior, Depression, and Cognitive Function in Older Men With Mild Cognitive Loss
J. Gerontol. A Biol. Sci. Med. Sci.,
January 1, 2004;
59(1):
M75 - 78.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Lee, N. Berman, G. M. Alexander, L. Hull, R. S. Swerdloff, and C. Wang
A Simple Self-Report Diary for Assessing Psychosexual Function in Hypogonadal Men
J Androl,
September 1, 2003;
24(5):
688 - 698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Arehart-Treichel
Testosterone May Boost Efficacy Of Antidepressants in Men
Psychiatr News,
February 7, 2003;
38(3):
26 - 38.
[Full Text]
|
|
|
|
|
|
|
Adjunctive Testosterone for Refractory Depression?
Journal Watch Psychiatry,
February 5, 2003;
2003(205):
2 - 2.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
